$Algorhythm (RIME.US)$ Algorhythm Pauses Capital Raising, Plans Reverse Stock Split for Nasdaq Compliance

$Eyenovia (EYEN.US)$ Eyenovia, Inc. Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of common stock, 0.0001 par value per share (the “common stock”), at a ratio of between 1:40 and 1:80

$Applied Therapeutics (APLT.US)$ Applied Therapeutics CEO Shendelman Steps Down

$Applied Therapeutics (APLT.US)$ Applied Therapeutics Inc : RBC Cuts Target Price to $1.5 From $4

$Canoo (GOEV.US)$ Canoo Inc. Announces 1-for-20 Reverse Stock Split Effective December 24, 2024

$Nukkleus (NUKK.US)$ Company is planning to issue an aggregate of 1,666,666 units (the "Offering"). Each unit will be sold at an effective unit price of $6.00 per unit and will consist of one share of restricted common stock (or one pre-prefunded warrant to purchase a share of restricted common stock), and warrants exercisable for one and one-half shares of restricted common stock, exercisable at $6.00 per share. The Offering is priced above-the-market under Nasdaq rules.

$Algorhythm (RIME.US)$ Algorhythm Holdings Announces $2M Registered Direct Offering For 24.1M Shares At $0.0831 Per Share, Closing Expected December 18, 2024

$WeBuy Global (WBUY.US)$ Webuy Global Announces Pricing Of $3.7M Registered Direct Offering Of 21,013,239 Class A Ordinary Shares At A Purchase Price Of $0.1756 Per Share

$Conduit Pharmaceuticals (CDT.US)$ 100k😱buy

$Akoustis Technologies (AKTS.US)$ Akoustis Technologies (AKTS) said Monday it filed for a Chapter 11 relief in a bankruptcy court for the District of Delaware.